EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Synthesis and Preclinical Evaluation of 22-[ 18 F]Fluorodocosahexaenoic Acid as a Positron Emission Tomography Probe for Monitoring Brain Docosahexaenoic Acid Uptake Kinetics

Marlon Vincent V Duro, Juno Van Valkenburgh, Diana E Ingles, Jenny Tran, Zhiheng Cai, Brandon Ebright iD, Shaowei Wang, Bilal E Kerman iD, Jasmin Galvan, Sung Hee Hwang iD, Naomi S Sta Maria, Francesca Zanderigo und 7 weitere

ACS Chemical Neuroscience · 2023

DOI: 10.1021/acschemneuro.3c00681 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Chemical Neuroscience, 2023. Verfasst von Marlon Vincent V Duro und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Keck School of Medicine, University of Southern California, Los Angeles, California 90033, United States. Hauptthemen laut MEDLINE: Docosahexaenoic Acids, Alzheimer Disease. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, Alzheimer's Drug Discovery Foundation, National Institute on Aging.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Docosahexaenoic acid [22:6(n-3), DHA], a polyunsaturated fatty acid, has an important role in regulating neuronal functions and in normal brain development. Dysregulated brain DHA uptake and metabolism are found in individuals carrying the APOE4 allele, which increases the genetic risk for Alzheimer's disease (AD), and are implicated in the progression of several neurodegenerative disorders. However, there are limited tools to assess brain DHA kinetics in vivo that can be translated to humans. Here, we report the synthesis of an ω-radiofluorinated PET probe of DHA, 22-[18F]fluorodocosahexaenoic acid (22-[18F]FDHA), for imaging the uptake of DHA into the brain. Using the nonradiolabeled 22-FDHA, we confirmed that fluorination of DHA at the ω-position does not significantly alter the anti-inflammatory effect of DHA in microglial cells. Through dynamic PET-MR studies using mice, we observed the accumulation of 22-[18F]FDHA in the brain over time and estimated DHA's incorporation coefficient (K*) using an image-derived input function. Finally, DHA brain K* was validated using intravenous administration of 15 mg/kg arecoline, a natural product known to increase the DHA K* in rodents. 22-[18F]FDHA is a promising PET probe that can reveal altered lipid metabolism in APOE4 carriers, AD, and other neurologic disorders. This new probe, once translated into humans, would enable noninvasive and longitudinal studies of brain DHA dynamics by guiding both pharmacological and nonpharmacological interventions for neurodegenerative diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Docosahexaenoic AcidsAlzheimer DiseaseHumansMiceAnimalsApolipoprotein E4BrainPositron-Emission TomographyBiological Transport

Stichwörter der Autor:innen

docosahexaenoic acidincorporation coefficientpolyunsaturated fatty acidpositron emission tomographyradiofluorination

Substanzen

Docosahexaenoic AcidsApolipoprotein E4

Autor:innen und Institutionen

  • Department of Radiology, Keck School of Medicine, University of Southern California, Los Angeles, California 90033, United States.
  • Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California 90033, United States.
  • Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences, University of Southern California, Los Angeles, California 90089, United States.
  • Department of Entomology and Nematology and UC Davis Comprehensive Cancer Center, University of California, Davis, California 95616, United States.
  • Zilkha Neurogenetic Institute, Keck School of Medicine, University of Southern California, Los Angeles, California 90033, United States.
  • Department of Psychiatry, Columbia University, New York, New York 10032, United States.

ORCID-Profile: Brandon Ebright, Bilal E Kerman, Sung Hee Hwang, Kai Chen

Förderung

  • NIA NIH HHS
  • Alzheimer's Drug Discovery Foundation
  • National Institute on Aging
  • Tiny Foundation
  • Vranos
  • Ms. Lynne Nauss

Zitieren

APA

Duro, M. V. V., Van Valkenburgh, J., Ingles, D. E., Tran, J., Cai, Z., Ebright, B., Wang, S., Kerman, B. E., Galvan, J., Hwang, S. H., Sta Maria, N. S., Zanderigo, F., Croteau, E., Cunnane, S. C., Rapoport, S. I., Louie, S. G., Jacobs, R. E., Yassine, H. N., & Chen, K. (2023). Synthesis and Preclinical Evaluation of 22-[ 18 F]Fluorodocosahexaenoic Acid as a Positron Emission Tomography Probe for Monitoring Brain Docosahexaenoic Acid Uptake Kinetics. ACS Chemical Neuroscience. https://doi.org/10.1021/acschemneuro.3c00681

Vancouver

Duro MVV, Van Valkenburgh J, Ingles DE, Tran J, Cai Z, Ebright B, et al. Synthesis and Preclinical Evaluation of 22-[ 18 F]Fluorodocosahexaenoic Acid as a Positron Emission Tomography Probe for Monitoring Brain Docosahexaenoic Acid Uptake Kinetics. ACS Chemical Neuroscience. 2023. doi:10.1021/acschemneuro.3c00681

BibTeX
@article{Duro2023,
  author = {Duro, Marlon Vincent V and Van Valkenburgh, Juno and Ingles, Diana E and Tran, Jenny and Cai, Zhiheng and Ebright, Brandon and Wang, Shaowei and Kerman, Bilal E and Galvan, Jasmin and Hwang, Sung Hee and Sta Maria, Naomi S and Zanderigo, Francesca and Croteau, Etienne and Cunnane, Stephen C and Rapoport, Stanley I and Louie, Stan G and Jacobs, Russell E and Yassine, Hussein N and Chen, Kai},
  title = {Synthesis and Preclinical Evaluation of 22-[ 18 F]Fluorodocosahexaenoic Acid as a Positron Emission Tomography Probe for Monitoring Brain Docosahexaenoic Acid Uptake Kinetics},
  journal = {ACS Chemical Neuroscience},
  year = {2023},
  doi = {10.1021/acschemneuro.3c00681}
}
Kostenlos starten →